Loading...
Symbols:
HHV Forum Topics
- All Comments on HHV
- General Discussion on HHV
- A Healthcare ETF Strategy To Outpace the Market [view article]
- Watch Expenses & Spreads For HealthShares, PowerShares, WisdomTree ETFs [view article]
- Interview With X-Shares Founder & Chairman, Jeffrey Feldman [view article]
- Healthcare, Pharma and Biotech ETFs [view article]
- Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
- Sixty-Seven ETF Filings For a New Year [view article]
Recent HHV Articles
- A Healthcare ETF Strategy To Outpace the Market
- Affymetrix Remains a Value Trap Until Its Results Improve
- The Top 3 ETFs for Healthcare Investing
- Interview With X-Shares Founder & Chairman, Jeffrey Feldman
- Watch Expenses & Spreads For HealthShares, PowerShares, WisdomTree ETFs
- Healthcare, Pharma and Biotech ETFs
- Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC
- Exotic ETFs Can Be Useful
- Healthshares Debuts Five New ETFs: Are the Funds Too Narrowly Focused?
- New HealthShares ETFs To Launch Today
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
A Healthcare ETF Strategy To Outpace the Market [view article]
Failing Economy Predicts Worse Health:"...each percentage-point rise in unemployment would result in an additional 1.1 million people losing health insurance"
www.time.com/time/busi... Reply
A Healthcare ETF Strategy To Outpace the Market [view article]
On a related topic, "medical tourism", this addresses the gross inefficiency of the US medical system. It might remind you of a few other industries.www.economist.com/disp... Reply
A Healthcare ETF Strategy To Outpace the Market [view article]
This is just an incredibly irrational market. Financials down 20%, up 30%. Oil up 60%, down 30%. Money rushes into this sector, then that sector. So right now, tech and health are the hot sectors. Anything fundamental going on here? Sure, just like oil went to $147 and back to $115 on "supply and demand". Follow the trend while it lasts, but don't tell me it is anything more than the latest fad, destined to follow the no-longer-latest fads.Healthcare is bloated almost as much as government. They've been the last sectors still increasing employment. Consumers are having an increasingly difficult time paying insurance and medical bills. The sector is horribly inefficient and financially irrational. What do you think is going to happen as more workers lose their jobs, and therefore medical insurance? I just had a not-too-major surgery that was about $3000 after insurance (interestingly, nearly $30,000 before my PPO discount). Many families would find that a serious if not disastrous problem. One of the leading causes of bankruptcy is unexpected medical expense.
The healthcare sector is going to get beaten to death over the new few years between high costs and decreasing ability of consumers to pay for it. A lot of health care is discretionary. Even if you need it, many medical expenses can and will be put off. And speaking of bloated, government at all levels (the #1 addition to employment in the last few years) is going to get crunched big-time by falling revenues. Borrowing only works so long; then you have to actually cut spending. What's that going to do to the healthcare industry?
The hot money will flee tech and healthcare in due time, leaving all the later-coming trend followers holding the bag. Those of you who bought commodities late know the feeling. Reply
A Healthcare ETF Strategy To Outpace the Market [view article]
This sector as well as small caps seem to be the new sectors of choice for this latest rotation. ReplyEditors
General Discussion on HHV
Is this a buy or a sell? ReplyHealthcare, Pharma and Biotech ETFs [view article]
The Matt Hougan article on theme ETF expenses is helpful -- thanks for the pointer. He's right -- makes you want to buy the stocks of the ETF firms more than the ETFs themselves. ReplyWatch Expenses & Spreads For HealthShares, PowerShares, WisdomTree ETFs [view article]
Very interesting article. Spreads and expenses are rising on the new specialty ETFs, while the broad index ETFs are getting cheaper due to competition (eg. the new bond ETFs from State Street and Vanguard).Perhaps investors who want to play themes, (like healthcare subsectors and "green" investing) just don't care about expenses. If that's correct, the specialty ETF providers will have very profitable businesses. Reply
Editors
Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
Having hit the time limit on this interactive Q&A, we're now closing it to further questions.Many thanks to Mr Feldman for his participation, and to Seeking Alpha's readers for their questions and comments. Reply
Jackson
Healthcare, Pharma and Biotech ETFs [view article]
Have we missed out any ETFs here? Or any Seeking Alpha articles that are important to understanding them? If so, please leave a comment and let us know! ReplyInteractive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
Thanks, Tom. No, I have no formal training in either medicine or healthcare. I do have close to 40 years on Wall Street and I have taught macroeconomics for nearly that long. I started my career as an analyst at Goldman, Sachs and then started my own firm in the 70's. I have spent my life studying the nexus of the capital markets and the macro-economy and have devoted my business career to developing capital market tools when I think they are needed. I became sensitized to the current healthcare crisis in the US about 8 years ago and recognized that we needed to find a way to invest in the innovations that might alleviate the crisis. Thus began a journey that led me to create HealthShares. It may appear that we have burst on the scene, but this has been a long slog. The press may have have its fun calling me stupid, but I can assure all that a great deal of effort and thought went into the creation of this product. ReplyInteractive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
Jeff-I caught a portion of your presentation at the World Series of ETFs in Miami a few weeks ago. Nice Job. It's apparent you're either educated in the medical area or have some experience in the health care arena. Would you mind sharing a little more about your background? It's refreshing to see a CEO with the in-depth knowledge and enthusiasm in the products offered.
Not a bad week for performance and fund flow for HealthShares funds either.
Thank you,
Tom Lydon
ETFtrends.com Reply
Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
The expense ratio for HealthShares Therapeutic ETFs is 75 basis points. Our European Drugs ETF has a 95 basis point expense cap. Although 75 bps is higher than many other ETFs, it is roughly equivalent to the expense load of other specialized products.WTFs, like other index funds in general, generate fewer capital gains due to low turnover of the securities in the portfolio. Generally, ETFs only sell securities to reflect changes in their benchmark index.
Investors in mutual funds may incur significant tax expense when the fund sees redemptions from shareholders. Because ETFs are exchange-traded, selling shareholders sell to other investors in the secondary market. In addition, since ETFs have a creation/redemption facility that allows actual securities, rather than cash, to be distributed to Authorized Participants, there is no realization of capital gain to be distributed to shareholders. Of course, liquidating an ETF position will generate capital gains or losses for the shareholder. Reply
Jackson
Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
FYI for readers:ProFunds provides inverse ETFs (ETFs that provide the opposite performance to an index, so if the index rises the ETF falls -- a short bet), leveraged ETFs (ETFs that provide twice the performance of an index, so if the index rises by 1% the ETF rises by 2%), and short leveraged ETFs (if the index rises by 1%, the ETF falls by 2% -- a strong short bet). The ProFunds family includes inverse and leveraged ETFs covering the main indexes, growth and value, and individual sectors.
You can find articles on the ProFunds ETFs here. Reply
Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
I cannot comment about carbon credits at this time.As to State Shares, I believe many investors will be interested in these securities.
I have a hard time understanding why investors want to put significant assets into emerging markets. Peter Lynch has always said, "invest in what you know." Investing in emerging markets is investing in what you know....nothing about. But investors are seeking to isolate asset classes.
Personally, I'd rather isolate California and invest there as opposed to Turkey or Malaysia. Maybe that's just me.
Your conjecture about state governments is correct. Reply
Interactive Q&A: Jeffrey L. Feldman, Creator of HealthShares and Founder and Chairman of XShares Group LLC [view article]
ETFs are here to stay and will be a significant asset class. Mutual funds and ETFs will co-exist. There will be ETFs of mutual funds and mutual funds of ETFs. Some mutual fund sponsors will find they can best grow their assets under management by creating ETFs.To some extent, growth of ETFs will be a function of what happens in the stock market. I believe the biggest impediment to asset growth would be a roaring bull market. In such a scenario, greed routs fear and individuals are emboldened to buy the individual stocks that are rising the fastest. In a prolonged bear or sideways market, fear wins out and investors will seek to minimize costs which favors ETFs.
The ETF industry can be as profitable as the mutual fund business. Technology will continue to evolve and we will likely see costs decline faster than expense loads over the next several years. Of course, the wild card is what happens in the mutual fund industry. If mutual funds can become competitive with ETFs on fees and expenses, then the margins for ETFs will be squeezed. Reply